Physician

Aaron Jeffrey Reiprich, D.O.

According to 2025 Medicare claims, Aaron Reiprich, D.O. (NPI: 1306287560) practices gastroenterology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Dauphin, PA. This provider's primary affiliated billing organization is HARRISBURG GASTROENTEROLOGY, LTD. (NPI: 1639121809; TIN: 232180822) and primary practice location at 17111-3744.

Reiprich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 542 traditional Medicare patients, billed 8,554 HCPCS/CPT codes, and received $226,220 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 908 prescription claims across 199 beneficiaries totaling $377,658 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 75 records totaling $1,062. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $60,892 to $226,220. Similarly, Part D prescription costs have risen steadily, from $2,805 to $377,658. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$113K$226K2019 Medicare payment: $60,892 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $94,003 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $109,370 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $129,120 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $116,856 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $226,220 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019278749$60,892
20204281,192$94,003
20214692,015$109,370
20224703,246$129,120
20235062,485$116,856
20245428,554$226,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$313K$625K2015 Drug cost: $2,805 (USD; Tot_Drug_Cst)2016 Drug cost: $1,798 (USD; Tot_Drug_Cst)2019 Drug cost: $83,898 (USD; Tot_Drug_Cst)2020 Drug cost: $538,249 (USD; Tot_Drug_Cst)2021 Drug cost: $286,403 (USD; Tot_Drug_Cst)2022 Drug cost: $348,638 (USD; Tot_Drug_Cst)2023 Drug cost: $625,276 (USD; Tot_Drug_Cst)2024 Drug cost: $377,658 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R23$2,805
20161323$1,798
2017N/RN/RN/R
2018N/RN/RN/R
2019103157$83,898
2020156389$538,249
2021138537$286,403
2022146603$348,638
2023167663$625,276
2024199908$377,658

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes134138$104
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope5356$91
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes61101$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more95111$61
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes121127$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LinzessLinaclotide552,550$44,107
ViberziEluxadoline11330$12,537
Budesonide ErBudesonide11330$8,477
TrulancePlecanatide14420$7,311
Budesonide EcBudesonide19897$6,974

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.75$1,062ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aaron Jeffrey Reiprich, D.O.?

Tedicare shows public-source Medicare data for Aaron Jeffrey Reiprich, D.O. (NPI 1306287560), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Jeffrey Reiprich, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Jeffrey Reiprich, D.O.?

Aaron Jeffrey Reiprich, D.O. is linked to HARRISBURG GASTROENTEROLOGY, LTD. (billing NPI 1639121809) in the available physician profile data.

Does Aaron Jeffrey Reiprich, D.O. have Open Payments data?

Aaron Jeffrey Reiprich, D.O. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.